Forsythoside B

Forsythoside B
Product Name Forsythoside B
CAS No.: 81525-13-5
Catalog No.: CFN99715
Molecular Formula: C34H44O19
Molecular Weight: 756.70 g/mol
Purity: >=98%
Type of Compound: Phenylpropanoids
Physical Desc.: Powder
Targets: TNF-α | IL Receptor | NF-kB | HMGB1 | MPO
Source: The fruits of Forsythia suspensa
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $50/20mg
Forsythoside B inhibits inflammatory response, has antioxidant, antisepsis properties, and also has potent neuroprotective effects with a favorable therapeutic time-window, reduce of cerebral ischemia and reperfusion injury degree, attenuating blood-brain barrier (BBB) breakdown. Forsythoside B could inhibit TNF-alpha, IL-6, IκB and modulate NF-κB.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Biomolecules2021, 11(10),1513.
  • Front Plant Sci.2022, 13:982771.
  • Life Sci.2021, 270:119074.
  • Front Pharmacol.2020, 11:251.
  • Cardiovasc Toxicol.2021, 21(11):947-963.
  • Scientific World Journal.2014, 2014:654193
  • Evid Based Complement Alternat Med.2021, 2021:8707280.
  • Molecules.2019, 24(10):E1926
  • Food Analytical Methods2020, 1-10
  • CZECH MYCOLOGY2021, 73(1):1-19.
  • 6-O-Caffeoylarbutin

    Catalog No: CFN99427
    CAS No: 136172-60-6
    Price: Inquiry(manager@chemfaces.com)
    Erigeside I

    Catalog No: CFN96865
    CAS No: 224824-74-2
    Price: $513/5mg
    Calceolarioside B

    Catalog No: CFN90647
    CAS No: 105471-98-5
    Price: $238/20mg
    Calceolarioside A

    Catalog No: CFN98522
    CAS No: 84744-28-5
    Price: Inquiry(manager@chemfaces.com)
    Desrhamnosylmartynoside

    Catalog No: CFN89370
    CAS No: 136055-64-6
    Price: Inquiry(manager@chemfaces.com)
    Cistantubuloside B1

    Catalog No: CFN95714
    CAS No: 130009-44-8
    Price: $318/5mg
    Forsythoside B

    Catalog No: CFN99715
    CAS No: 81525-13-5
    Price: $50/20mg
    Poliumoside

    Catalog No: CFN99714
    CAS No: 94079-81-9
    Price: $80/20mg
    Brandioside

    Catalog No: CFN90882
    CAS No: 133393-81-4
    Price: $318/10mg
    Echinacoside

    Catalog No: CFN98105
    CAS No: 82854-37-3
    Price: $30/20mg
    Phytother Res. 2012 Jul;26(7):981-7.
    Forsythoside B protects against experimental sepsis by modulating inflammatory factors.[Pubmed: 22147417]

    METHODS AND RESULTS:
    The present study investigated the effects of Forsythoside B on an experimental model of sepsis induced by caecal ligation and puncture (CLP) in rats and elucidated the potential mechanism in cultured RAW 264.7 cells. Results showed that Forsythoside B concentration-dependently down-regulated the levels of TNF-α, IL-6 and high-mobility group-box 1 protein (HMGB1) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells, inhibited the IκB kinase (IKK) pathway and modulated nuclear factor (NF)- κB. Intravenous injection (i.v.) of Forsythoside B alone or plus Imipenem reduced serum levels of TNF-α, IL-6, HMGB1, triggering receptor expressed on myeloid cells (TREM-1) and endotoxin, while the serum level of IL-10 was up-regulated and myeloperoxidase (MPO) in lung, liver and small intestine was reduced. Meanwhile, i.v. of Forsythoside B alone or plus Imipenem reduced CLP-induced lethality in rats. These data indicated that the antisepsis effect of Forsythoside B is mediated by decreasing local and systemic levels of a wide spectrum of inflammatory mediators. Its antisepsis mechanism may be that Forsythoside B binds to LPS and reduces the biological activity of serum LPS, and inhibits NF-κB activition.
    CONCLUSIONS:
    Our studies enhance the case for the use of Forsythoside B in sepsis. Forsythoside B itself has promise as a therapy for the treatment of sepsis in humans.
    Phytomedicine. 2010 Jul;17(8-9):635-9.
    Cardioprotection with forsythoside B in rat myocardial ischemia-reperfusion injury: relation to inflammation response.[Pubmed: 19959348]
    The present study was undertaken to examine the effect of Forsythoside B (FB) on rat myocardial ischemia-reperfusion (I/R) model and elucidate the potential mechanism.
    METHODS AND RESULTS:
    Left ventricular systolic pressure (LVSP) and +/-dp/dt(max) were detected. Blood samples were collected to determine serum levels of troponin T (Tn-T), TNF-alpha and IL-6. Hearts were harvested to assess histopathological change and infarct size, determine content of MDA, myeloperoxidase (MPO), SOD and GPx activities, analyze expression of high-mobility group box 1 (HMGB1), phosphor-I kappaB-alpha and phosphor-nuclear factor kappaB (NF-kappaB) in ischemic myocardial tissue by Western blot. Compared with control group, rats treatment with FB showed a significant recovery in myocardial function with improvement of LVSP and +/-dp/dt(max). The myocardial infarct volume, serum levels of Tn-T, TNF-alpha and IL-6, content of MDA and MPO activity in myocardial tissue were all reduced, protein expression of HMGB1, phosphor-I kappaB-alpha and phosphor-NF-kappaB were down-regulated, while attenuated the decrease of SOD and GPx activities. Besides, the infiltration of polymorph nuclear leukocytes (PMNs) and histopathological damages in myocardium were decreased in FB treated groups.
    CONCLUSIONS:
    These findings suggested that FB rescued cardiac function from I/R injury by limiting inflammation response and its antioxidant properties.
    Eur J Pharmacol. 2010 Aug 25;640(1-3):75-81.
    Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury.[Pubmed: 20470770]
    The present study was to investigate the neuroprotective efficacy and mechanism of Forsythoside B.
    METHODS AND RESULTS:
    Male Sprague-Dawley rats were subjected to middle cerebral artery occlusion for 1 h followed by reperfusion for 23 h. Rats received an intravenous bolus injection of Forsythoside B at 15 min after reperfusion. The results showed that Forsythoside B at doses higher than 8 mg/kg produced a significant neuroprotective potential in cerebral ischemia and reperfusion rats. Forsythoside B (20 mg/kg) demonstrated significant neuroprotective activity even after delayed administration at 1 h, 3 h and 5 h after cerebral ischemia and reperfusion. Forsythoside B 20 mg/kg attenuated histopathological damage as demonstrated by smaller brain infarct size and brain edema, decreased cerebral Evans blue extravasation and myeloperoxidase (MPO) activity, inhibited cerebral phosphor-IkappaB-alpha and nuclear transcription factors kappaB (NF-kappaB) expression. Meanwhile, NF-kappaB expression with immunohistochemical staining was reduced, while circulating polymorphonuclear leukocytes was increased.
    CONCLUSIONS:
    All of these findings suggested that Forsythoside B exerted potent neuroprotective effects with a favorable therapeutic time-window, reduce of cerebral ischemia and reperfusion injury degree, attenuating blood-brain barrier (BBB) breakdown, and its protective effects may be due to inhibition of inflammatory response.
    Zhongguo Zhong Yao Za Zhi. 2014 May;39(9):1630-4.
    [Caffeoyl phenylethanoid glycosides from Callicarpa kwangtungensis].[Pubmed: 25095374]

    METHODS AND RESULTS:
    Phytochemical investigation on the EtOH extract from the aerial part of Callicarpa kwangtungensis led to the isolation and characterization of 10 caffeoyl phenylethanoid glycosides, 2'-acetylacteoside (1), tubuloside E (2), acteoside (3), tubuloside B (4), isoacteoside (5), alyssonoside (6), 2'-acetylForsythoside B (7), brandioside (8), Forsythoside B (9), and poliumoside (10).
    CONCLUSIONS:
    Compound 4 was isolated from the plants of Verbenaceae,and 6 was obtained from the Callicarpa genus, for the first time, while compounds 1, 2, 5 and 7 were firstly reported from the plant.
    Iristectorin A

    Catalog No: CFN95037
    CAS No: 37744-61-9
    Price: $318/20mg
    3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al

    Catalog No: CFN95168
    CAS No: 1446447-97-7
    Price: $318/5mg
    4,4-di(4-hydroxy-3-methoxyphenly)-2,3-dimethylbutanol

    Catalog No: CFN95200
    CAS No: 913643-31-9
    Price: $368/5mg
    7-O-(4-beta-D-glucopyranosyloxy-3-methoxybenzoyl)secologanolic acid

    Catalog No: CFN95365
    CAS No: 469899-55-6
    Price: $368/5mg
    10-O-trans-p-Feruloylscandoside

    Catalog No: CFN95392
    CAS No: 1428268-72-7
    Price: $318/10mg
    Bergamjuicin

    Catalog No: CFN95422
    CAS No: 2376307-20-7
    Price: $318/5mg
    Cannabisin P

    Catalog No: CFN95456
    CAS No: 2756983-19-2
    Price: $318/5mg
    Butesuperin B-7''-O-beta-glucopyranoside

    Catalog No: CFN95502
    CAS No: N/A
    Price: $413/5mg
    Quercetin-3-O-[alpha-L-rhamnose-(1->2)-beta-D-glucopyranosyl]-5-O-beta-D-glucopyranoside

    Catalog No: CFN95506
    CAS No: 1309795-36-5
    Price: $318/5mg
    Methyl ganoderate E

    Catalog No: CFN95582
    CAS No: 98718-43-5
    Price: $413/5mg